Related Experiment Video
Updated: May 10, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
901
Detection of Alzheimer's Disease using Explainable Machine Learning and Mathematical Models
Krishna Mahapatra1, R Selvakumar1
1Department of Mathematics, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Journal of Medical Physics
|April 21, 2025
Summary
This study uses mathematical modeling and machine learning to classify Alzheimer's disease (AD) stages from MRI scans, achieving 95.45% accuracy with the Gaussian Naïve Bayes classifier.
Area of Science:
- Neuroimaging
- Machine Learning
- Mathematical Modeling
Background:
- Alzheimer's disease (AD) diagnosis relies on accurate staging.
- Magnetic Resonance Imaging (MRI) provides detailed brain structure information.
- Current classification methods can be improved for accuracy and efficiency.
Purpose of the Study:
- To develop a novel approach for classifying four Alzheimer's disease (AD) stages using MRI scans.
- To integrate mathematical modeling with machine learning (ML) for enhanced diagnostic capabilities.
- To explore the utility of physical concepts like moment of inertia tensors in neuroimaging analysis.
Main Methods:
- MRI pixel value matrices were mapped to 2x2 matrices using moment of inertia (MI) tensor principles.
- Eigenvalues of the inertia tensor were utilized in conjunction with ML algorithms.
- Various ML models were evaluated for their performance in classifying AD stages.
Main Results:
- The Gaussian Naïve Bayes classifier demonstrated the highest accuracy at 95.45%.
- The integrated mathematical and ML approach proved effective in distinguishing AD stages.
- Performance comparisons were made across multiple ML models.
Conclusions:
- The proposed method achieves high accuracy in Alzheimer's disease (AD) staging from MRI.
- The approach offers computational efficiency through dimensionality reduction.
- Inertia tensor analysis provides novel physical insights into AD progression.
Related Concept Videos
Alzheimer's Disease: Overview
317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
26
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
26
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128

